Proteomics Market (By Product: Instruments, Consumables and reagents, Services; By Application: Drug Discovery, Clinical Diagnostics, Others; By Technology: Spectroscopy, Microarray instruments, Chromatography, X-ray crystallography, Protein Microarrays, Electrophoresis, Protein fractionation system, Surface plasma resonance systems; By Software & Service; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030


The global proteomics market size was exhibited at USD 26.1 billion in 2021 and it is expected to hit around USD 74.8 billion by 2030, poised to reach at a compound annual growth rate (CAGR) of 12.41% during the forecast period 2022 to 2030.

Proteomics Market Size 2022 To 2030

Key Takeaways:

  • North America region accounted for 46.2% of the total revenue share in 2021.
  • By products, the consumables and the reagents segment accounted for 71.5% of revenue share in 2021.
  • By technology, the spectroscopy segment has captured 47.6% revenue share in 2021.
  • By application, the clinical diagnostics segment has held a revenue share of over 51.8% in 2021.

Proteomics is the most evolved field of the diagnosis of the disease which is changing rapidly. Proteomics is used for the identification of the proteins that are present in a particular disease and it helps in understanding their expression structure as well as function. Prognostic markers can also be identified with the proteomic study and it helps in the diagnosis of cancer, malaria, tuberculosis, and different types of infectious diseases. When it comes to the use of proteomics in the industry of drugs it plays a very significant role in the investigation of the mechanical happening or the functioning of the drug. Drug development makes use of proteomics and many proteomic divisions are started by various manufacturers in order to increase their efficiency. The proteomics market is expected to grow well during the forecast period.

Many important contributions have been made by proteomic research in the field of personalized medicines. One of the most promising and effective approaches against cancer is personalized medicines and these medicines are developed with the help of proteomics. 

Proteomics plays a very significant role against extremely rare conditions that are genetic and also against neurodegenerative diseases. Significant information about the tumor in a person and the planning of the treatment can be made with the help of proteomics which helps in the making of the personalized diseases which can be prescribed depending upon the condition of the patient.

Growth Factors

Personalized therapy has grown significantly and the demand for this kind of therapy is expected to grow even in the coming years due to which the demand for proteomics will also grow during the forecast period. Advanced kind of protein interactions has played an extremely significant role in the making of personalized medicines. There are many applications of proteomics, especially in the field of nanotechnology. It has applications like nanostructured surfaces which are for protein separation and metal oxide nanoparticles. The recently emerging field of nano proteomics is expected to grow significantly in the coming years and provide major opportunities for the growth of the market during the forecast period.

In the future, many new technologies are expected to be incorporated into proteomics due to an increased number of efforts taken in the research and developmental activities through technical and monetary ways. In recent years cases of cancer have increased in the recent years and the number of genetic disorders has also grown to a great extent the demand for proteomics is expected to grow significantly in the coming years. Characterization of the human protein is a major milestone in biomedicine which is an extremely new and dynamic type of science that focuses majorly on the understanding of gene expression at the level of proteome.

  • The number of investments made in the research and development activities for the proteomics market has increased significantly
  • The National Institute of Health provided the U.S. dollars 37 billion for research in the biomedical field. It helps in understanding the fundamental process through which a disease develops The identification of the biomarkers which implies a particular disease.
  • As the diseases like cancer have also grown considerably the market is expected to grow well in the coming years.
  • Considerable progress is seen in the technology which is new in the market. The combination of proteomics with nanotechnology will provide good opportunities for the growth of the business in the coming years.

Report Scope of the Proteomics Market

Report Coverage Details
Market Size in 2022 USD 29.34 Billion
Market Size by 2030 USD 74.8 Billion
Growth Rate from 2022 to 2030 CAGR of 12.41%
Largest Market North America 
Fastest Growing Market Asia Pacific 
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered
  • By Product
  • By Application
  • By Technology
  • By Software & Service
  • By End User
Regions Covered
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa


Key Market Drivers

  • Increase in the number of patients suffering from cancer - as a large number of populations across the world are suffering from cancer the need for treatment has grown significantly. Many new discoveries are also made in the life sciences field. Human protein characterization is seemed to be a milestone in biomedicines. Gene expression evaluation at the level of the proteome is also significant. Constant research and development in the field will lead to the growth of the proteomics market to a great extent. Extremely significant information which is biological could be extracted through the use of this technique and it will help in understanding the biology of patients that suffer from cancer.

Key Market Challenges

  • Expensive instruments - the need for a longer period of time in the laboratories increases the cost of the treatment. The instruments, as well as the reagents, used our expensive due to which the use of this technology in developing nations is limited. The most commonly used method of proteomics is X-ray crystallography which carries out protein expression and gene cloning. It also helps in protein crystallization as well as purification. As these procedures are time-consuming the process becomes expensive due to which the adoption of these procedures in developing nations will be less. This happens to be a major challenge in the growth of the market and it will hamper the growth of the market in the long run.

Key Market Opportunities

  • Introduction of nanotechnology - the use of nanotechnology in proteomics happens to be a new kind of technique that is expected to provide good opportunities for the growth of the market in the coming year. With the help of nanotechnology, proteomics will have several applications.

Segments Insight

Product Insights

Depending on the products, the consumables and the reagents segment are expected to have the largest market share in the coming years. Large scale use of the consumables and reagents, chemicals, kits, and strips that are used for the examination in various academic institutes and research labs the need for all of these products will lead to the growth of the segment. Research and development in the field have led to technological advancements and many new advanced instruments are introduced in the market.

Proteomics Market Share, By Product, 2021 (%)

These instruments help in increasing the speed as well as the efficiency of the process. It also plays a significant role in the outcome of biological research. Some of the most commonly used equipment are biochip analyzers and electrophoresis equipment. Due to constant advancement in the techniques used for automation, it is also in great demand as this is offered as a cost-effective way for analysts. The use of biochips is another breakthrough that has led to significant growth in the market. Innovative equipment introduced in the market we will prove to be a boon for the growth of this market in the long run.

Application Insights

The segment of clinical diagnostics will have the largest market share in the coming years and the segment has dominated the market in the past with a share of about 53% in terms of revenue. Increased use of the method of proteomics for the identification of various diseases will lead to the growth of the market in the coming years. Diseases are detected earlier which also helps in removing the risk of mortalities. This method also helps in understanding the risk factors. Early detection of various diseases will prove to be a major opportunity for the growth of this technique in the coming years. Understanding potential biomarkers can be identified through the help of proteomics. It also helps in the identification and classification of tumors.

Proteomics Market Share, By Application, 2021 (%)

The drug discovery segment is also expected to show significant growth and it will expand at the fastest compound annual growth rate in the coming years. Drug design that is structure-based will be developed and it will provide major growth in the market. Growing demand for personalized drugs has also played a significant role in the growth of the market. Many new investments are seen in this field which are mainly due to the growing demand for personalized drugs. Early detection of various diseases also helps in the need for drugs. Drug discovery processes are enhanced due to the use of proteomics technology and it also helps in saving a lot of time for pharmaceutical companies. A lot of amounts of capital that is spent on this process can also be reduced due to the use of this technology. The healthcare system as well as the patients benefit due to this technology.

Technology Insights

Depending on the technology, the spectroscopy segment is expected to have the largest market share and it will generate maximum revenue. The extensive use of this technology for most of the processes and major applications of this technology in the development of drugs foreign sick analysis pharmaceutical analysis and proteomics metabolomics will lead to the growth of the market. This is one of the most widely used methods and it has grown significantly in recent years as it helps in the formation of drugs through various processes. The market growth will be supplemented due to the use of microarray techniques. The use of this analysis in antibiotic therapy is successful and this will play an instrumental role in the growth of the market. Microarrays that are DNA based are mostly preferred for the identification of gene expression. It helps in cost reduction and it also reduces the amount of complexity. This is the most widely used and available technology.

Proteomics Market Share, By Region, 2021 (%)

Regions Revenue Share in 2021 (%)
North America 46.2%
Asia Pacific 20.8%
Europe 25.1%
Latin America 5.1%
MEA 2.8%


Regional Insights

The largest revenue will be generated in the North American region. Constant research and development in the field and the use of high-quality tools for research purposes will lead to the growth of this market. The growing need for personalized medicines or tailor-made treatments will show up significant growth in the coming years due to which the need for proteomics will grow. Constant collaborations and partnerships amongst the market players will also help in the growth of this market. The Asia Pacific region will also show significant growth in the coming years as many projects that are proteomics based are outsourced to the countries in the Asia Pacific region. Government regulations in these regions are favorable due to which there's greater adoption of proteomics techniques.

Key Market Developments

  • Phitonex was acquired by Thermo Fisher Scientific in the year 2021
  • IP2 software of Integrated proteomics applications was acquired by Bruker corporation in the year 2020

Key Market Players

  • Thermo Fisher scientific
  • Alumna incorporated
  • Creative proteomics
  • GE healthcare
  • Integrated proteomics applications

Segments Covered in the Report

(Note*: We offer reports based on sub-segments as well. Kindly, let us know if you are interested)

By Product

  • Instruments
  • Consumables and reagents
    • Immunoassay Reagents
    • Spectroscopy Reagents
    • Chromatography Reagents
    • Protein Microarray Reagents
    • X-Ray Crystallography Reagents
    • Electrophoresis Reagents
    • Protein Fractionation Reagents
    • Services

By Application

  • Drug Discovery
    • Target Discovery
    • Lead Identification
    • Lead Optimization
    • Preclinical Studies
  • Clinical Diagnostics
    • Cancer
    • Immune Diseases
    • Infectious Diseases
    • Neurological Disorders
    • Diabetes
    • Cardiovascular Diseases
    • Other Clinical Diagnostic Applications
  • Others

By Technology

  • Spectroscopy
    • NMR Spectroscopy
    • CD Spectroscopy
    • Mass Spectroscopy
  • Microarray instruments
  • Chromatography
    • HPLC
    • Ion Chromatography
    • Affinity Chromatography
    • Supercritical Fluid Chromatography
  • X-ray crystallography
  • Protein Microarrays
    • Biochips
      • Lab-on-Chips
      • Protein Chips
    • Microarray Instruments
      • Integrated Systems
      • Microarray Scanners
      • Arrayers
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary Electrophoresis
  • Protein fractionation system
  • Surface plasma resonance systems

By Software & Service

  • Core Proteomics Services
    • Protein Identification Services
    • Protein Characterization Services
    • Quantitative Proteomic Services
    • Protein Purification Services
    • Protein Sequencing Services
    • Custom Assay Services
  • Bioinformatics Software & Services
    • Bioinformatics Software
    • Bioinformatics Tools
    • Bioinformatics Databases

By End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Academic Research Laboratories
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the proteomics market size?
The global proteomics market size was accounted at USD 26.1 billion in 2021 and it is expected to reach around USD 74.8 billion by 2030.
What will be the CAGR of global proteomics market?
The global proteomics market is poised to grow at a CAGR of 12.41% from 2022 to 2030.
Who are the prominent players operating in the proteomics market?
The major players operating in the proteomics market are Thermo Fisher scientific, Alumna incorporated, Creative proteomics, GE healthcare, Integrated proteomics applications
Which are the driving factors of the proteomics market?
Increase in the number of patients suffering with cancer, growing need for personalized medicines and drugs discovery these are driving the growth of the proteomics market.
Which region will lead the global proteomics market?
North America region will lead the global proteomics market during the forecast period 2022 to 2030.
  • Report Code:2306
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:October 2022

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 1900
   USD 1200

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample